High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease
- 31 July 1992
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 121 (1) , 93-97
- https://doi.org/10.1016/s0022-3476(05)82551-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High-dose intravenous gammaglobulin in rhesus-haemolytic diseaseThe Lancet, 1991
- Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: Report of a pilot studyThe Journal of Pediatrics, 1989
- Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.BMJ, 1989
- High-Dose Intravenous Immunoglobulin as the Sole Prenatal Treatment for Severe Rh ImmunizationNew England Journal of Medicine, 1988
- Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopeniaThe Journal of Pediatrics, 1987
- Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonatesThe Journal of Pediatrics, 1987
- Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia.Archives of Disease in Childhood, 1985
- RHESUS HAEMOLYTIC DISEASE TREATED WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1985
- Morbidity and mortality related to exchangetransfusionsThe Journal of Pediatrics, 1969
- Substitutive-Inhibitory Gamma Globulin Therapy as Prevention of Stillbirth in Rh–IncompatibilityActa Haematologica, 1965